Jefferies Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Jefferies Group’s Portfolio ACAD Stock Details ACAD Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-48,424	Closed	-$682K	–	1133
2022 Q2	$682K	Buy	+48,424	New	+$682K	0.01%	520
2021 Q2	–	Sell	-6,572	Closed	-$170K	–	1085
2021 Q1	$170K	Sell	6,572 -19,197	-74%	-$495K	﹤0.01%	917
2020 Q4	$1.38M	Buy	25,769 +23,395	+985%	+$1.25M	0.01%	456
2020 Q3	$98K	Buy	2,374 +800	+51%	+$33K	﹤0.01%	783
2020 Q2	$76	Sell	1,574 -227	-13%	-$11	﹤0.01%	698
2020 Q1	$74K	Buy	+1,801	New	+$74K	﹤0.01%	973
2019 Q4	–	Sell	-30,780	Closed	-$1.11M	–	1568
2019 Q3	$1.11M	Buy	+30,780	New	+$1.11M	0.01%	753
2018 Q4	–	Sell	-17,258	Closed	-$358K	–	1381
2018 Q3	$358K	Buy	+17,258	New	+$358K	﹤0.01%	1094
2018 Q1	–	Sell	-88,500	Closed	-$2.67M	–	1492
2017 Q4	$2.67M	Sell	88,500 -18,200	-17%	-$548K	0.01%	411
2017 Q3	$4.02M	Buy	106,700 +60,700	+132%	+$2.29M	0.03%	257
2017 Q2	$1.28M	Buy	46,000 +5,333	+13%	+$149K	0.01%	635
2017 Q1	$1.4M	Buy	40,667 +25,606	+170%	+$880K	0.01%	553
2016 Q4	$434K	Buy	15,061 +4,424	+42%	+$127K	﹤0.01%	887
2016 Q3	$338K	Sell	10,637 -2,403	-18%	-$76.4K	﹤0.01%	930
2016 Q2	$423K	Sell	13,040 -21,260	-62%	-$690K	﹤0.01%	748
2016 Q1	$959K	Buy	34,300 +28,600	+502%	+$800K	0.01%	498
2015 Q4	$203K	Sell	5,700 -30,353	-84%	-$1.08M	﹤0.01%	1060
2015 Q3	$1.19M	Buy	36,053 +6,471	+22%	+$214K	0.01%	503
2015 Q2	$1.24M	Buy	29,582 +13,982	+90%	+$586K	0.01%	522
2015 Q1	$508K	Buy	15,600 +2,600	+20%	+$84.7K	﹤0.01%	772
2014 Q4	$413K	Sell	13,000 -2,000	-13%	-$63.5K	﹤0.01%	728
2014 Q3	$371K	Sell	15,000 -7,020	-32%	-$174K	﹤0.01%	864
2014 Q2	$498K	Sell	22,020 -238	-1%	-$5.38K	﹤0.01%	701
2014 Q1	$542K	Sell	22,258 -52,347	-70%	-$1.27M	0.01%	637
2013 Q4	$1.86M	Buy	74,605 +24,205	+48%	+$605K	0.01%	227
2013 Q3	$1.38M	Sell	50,400 -12,104	-19%	-$332K	0.01%	328
2013 Q2	$1.14M	Buy	+62,504	New	+$1.14M	0.01%	309